Skip to main content

MoneyWorks4Me

Jenburkt Pharmaceuticals informs about compliances-certificate

08 Jul 2022 Evaluate
Jenburkt Pharmaceuticals has informed that it enclosed Certificate pursuant to regulation 74(5) of SEBI (D&P) Regulations, 2018 for the quarter ended on 30.06.2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1897.80
Dr. Reddys Labs. 1375.85
Cipla 1414.80
Lupin 2016.50
Zydus Lifesciences 1203.65
View more..